Key clinical point: The Psoriatic Arthritis Disease Activity Score (PASDAS) may be a better tool than the Disease Activity Score in 28 joints (DAS28) in assessing treat-to-target success in patients with psoriatic arthritis.
Major finding: Fewer patients reached low disease activity according to PASDAS (77.4%) versus DAS28 (53.1%).
Study details: Prospective cohort study (n = 855).
Disclosures: The study received no funding. The presenter had no relevant financial disclosures.
Mulder M et al. GRAPPA 2020 Virtual Annual Meeting.